ArticleTechnology in cancer research & treatment

Production of Long-Acting CNGRC-CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment.

Layla Al-Mansoori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.